Skip to Content

Books by Subject

Clinical Implementation Books

You are currently browsing 1–10 of 101 new and published books in the subject of Clinical Implementation — sorted by publish date from newer books to older books.

For books that are not yet published; please browse forthcoming books.

New and Published Books

  1. Clinical and Statistical Considerations in Personalized Medicine

    Edited by Claudio Carini, Sandeep M Menon, Mark Chang

    Series: Chapman & Hall/CRC Biostatistics Series

    The Future of Clinical Research and Health Care: From Empirical to Precision MedicineClinical and Statistical Considerations in Personalized Medicine explores recent advances related to biomarkers and their translation into clinical development. Leading clinicians, biostatisticians, regulators,...

    Published March 26th 2014 by Chapman and Hall/CRC

  2. Randomised Response-Adaptive Designs in Clinical Trials

    By Anthony C Atkinson, Atanu Biswas

    Series: Chapman & Hall/CRC Monographs on Statistics & Applied Probability

    Randomised Response-Adaptive Designs in Clinical Trials presents methods for the randomised allocation of treatments to patients in sequential clinical trials. Emphasizing the practical application of clinical trial designs, the book is designed for medical and applied statisticians, clinicians,...

    Published December 25th 2013 by Chapman and Hall/CRC

  3. Patient-Reported Outcomes

    Measurement, Implementation and Interpretation

    By Joseph C. Cappelleri, Kelly H. Zou, Andrew G. Bushmakin, Jose Ma. J. Alvir, Demissie Alemayehu, Tara Symonds

    Series: Chapman & Hall/CRC Biostatistics Series

    Advancing the development, validation, and use of patient-reported outcome (PRO) measures, Patient-Reported Outcomes: Measurement, Implementation and Interpretation helps readers develop and enrich their understanding of PRO methodology, particularly from a quantitative perspective. Designed for...

    Published December 19th 2013 by Chapman and Hall/CRC

  4. Benefit-Risk Assessment in Pharmaceutical Research and Development

    Edited by Andreas Sashegyi, James Felli, Rebecca Noel

    Series: Chapman & Hall/CRC Biostatistics Series

    Many practitioners in the pharmaceutical industry are still largely unfamiliar with benefit-risk assessment, despite its growing prominence in drug development and commercialization. Helping to alleviate this knowledge gap, Benefit-Risk Assessment in Pharmaceutical Research and Development provides...

    Published November 26th 2013 by Chapman and Hall/CRC

  5. Biosimilars

    Design and Analysis of Follow-on Biologics

    By Shein-Chung Chow

    Series: Chapman & Hall/CRC Biostatistics Series

    As many biological products face losing their patents in the next decade, the pharmaceutical industry needs an abbreviated regulatory pathway for approval of biosimilar drug products, which are cost-effective, follow-on/subsequent versions of the innovator’s biologic products. But scientific...

    Published July 28th 2013 by Chapman and Hall/CRC

  6. Optimal Design for Nonlinear Response Models

    By Valerii V. Fedorov, Sergei L. Leonov

    Series: Chapman & Hall/CRC Biostatistics Series

    Optimal Design for Nonlinear Response Models discusses the theory and applications of model-based experimental design with a strong emphasis on biopharmaceutical studies. The book draws on the authors’ many years of experience in academia and the pharmaceutical industry. While the focus is on...

    Published July 14th 2013 by CRC Press

  7. Applied Meta-Analysis with R

    By Ding-Geng (Din) Chen, Karl E. Peace

    Series: Chapman & Hall/CRC Biostatistics Series

    In biostatistical research and courses, practitioners and students often lack a thorough understanding of how to apply statistical methods to synthesize biomedical and clinical trial data. Filling this knowledge gap, Applied Meta-Analysis with R shows how to implement statistical meta-analysis...

    Published May 2nd 2013 by Chapman and Hall/CRC

  8. Randomized Phase II Cancer Clinical Trials

    By Sin-Ho Jung

    Series: Chapman & Hall/CRC Biostatistics Series

    In cancer research, a traditional phase II trial is designed as a single-arm trial that compares the experimental therapy to a historical control. This simple trial design has led to several adverse issues, including increased false positivity of phase II trial results and negative phase III trials...

    Published May 1st 2013 by Chapman and Hall/CRC

  9. A Practical Guide to Human Research and Clinical Trials

    By M. U. R. Naidu, P. Usha Rani

    Regulatory bodies such as the European Medicine Agency have done tremendous work in collaboration with experts from the field to develop Good Clinical Practices that apply not only in Europe but also in emerging countries. Designed to be a teaching aid and reference guide, A Practical Guide to...

    Published January 28th 2013 by CRC Press

  10. Design and Analysis of Bridging Studies

    Edited by Jen-pei Liu, Shein-Chung Chow, Chin-Fu Hsiao

    Series: Chapman & Hall/CRC Biostatistics Series

    As the development of medicines has become more globalized, the geographic variations in the efficacy and safety of pharmaceutical products need to be addressed. To accelerate the product development process and shorten approval time, researchers are beginning to design multiregional trials that...

    Published July 25th 2012 by Chapman and Hall/CRC